Stock Market News Stock Market News
  • Dow
  • S&P
  • Nasdaq
  • Stocks
  • ETFs
  • Bonds
  • Commodities
  • Earnings
  • Dividends
  • REITs
  • IPOs
  • Crypto
  • Forex
  • Tech
  • Politics
  • +

1 day Is Trending Stock Pfizer Inc. (PFE) a Buy Now? Zacks

Recently, Zacks.com users have been paying close attention to Pfizer (PFE). This makes it worthwhile to examine what the stock has in store.

Pfizer (PFE) · Pharmaceuticals

  X     

3 hours Dividend Roundup: Why I Prefer Johnson & Johnson Over Pfizer Seeking Alpha

   X     

3 hours Amneal (AMRX) Upgraded to Strong Buy: Here’s Why Zacks

   X     

4 hours Top 5 Commercial Biotech Buyout Candidates: Mirum Pharmaceuticals (No. 3) Seeking Alpha

   X     

15 hours West Pharmaceuticals: Cannot Wrap My Head Around Valuations (Rating Downgrade) Seeking Alpha

   X     

23 hours FDA requires GSK and Pfizer vaccines to carry rare side effect warnings Investing.com

   X     

1 day Will AbbVie (ABBV) Beat Estimates Again in Its Next Earnings Report? Zacks

   X     

1 day Why Pfizer (PFE) is a Top Value Stock for the Long-Term Zacks

   X     

2 days Alnylam Pharmaceuticals: Commercialization And Early-Stage Studies Are Likely To Drive 2025 Seeking Alpha

   X     

2 days Vertex Pharmaceuticals (VRTX) Stock Drops Despite Market Gains: Important Facts to Note Zacks

   X     

2 days Is it a Good Idea to Invest in Vanda Pharmaceuticals Stock Now? Zacks

   X     

2 days Best Momentum Stocks to Buy for January 6th Zacks

   X     

5 days Pfizer has increased prices on over 60 drugs in the U.S. as of Jan. 1 Fortune

   X     

5 days Amphastar Pharmaceuticals: Cheap With Caveats Seeking Alpha

   X     

5 days Biodexa Pharmaceuticals PLC Unsponsored ADR (BDRX) Moves to Buy: Rationale Behind the Upgrade Zacks

   X     

5 days Pfizer Rises 5.6% in a Month: How Should You Play the Stock? Zacks

   X     

5 days Pharma Stock Roundup: PFE Ends Hemophilia Deal With SGMO & More Zacks

   X     

5 days Pfizer: A Step-By-Step Strategy Before Earnings Seeking Alpha

   X     

6 days The Zacks Analyst Blog Eli Lilly, J&J, AbbVie, AstraZeneca and Pfizer Zacks

   X     

6 days The Zacks Analyst Blog Berkshire Hathaway, The Home Depot, Pfizer and AMREP Zacks

   X     

6 days Pfizer (PFE) Advances While Market Declines: Some Information for Investors Zacks

   X     

6 days Top Research Reports for Berkshire Hathaway, Home Depot & Pfizer Zacks

   X     

6 days Jefferies starts Rhythm Pharmaceuticals with Buy on obesity potential Yahoo Finance

   X     

6 days Here’s Why Pfizer (PFE) is a Strong Momentum Stock Zacks

   X     

6 days Sangamo Therapeutics Stock Plummets 56% After Pfizer Ends Hemophilia Treatment Partnership Yahoo Finance

   X     

6 days Crinetics Pharmaceuticals: Attractive Speculative Bet On Market Weakness Seeking Alpha

   X     

1 week Will Johnson & Johnson (JNJ) Beat Estimates Again in Its Next Earnings Report? Zacks

   X     

1 week Is ANI Pharmaceuticals (ANIP) Outperforming Other Medical Stocks This Year? Zacks

   X     

1 week Pfizer’s 2025 Comeback: What’s Driving Growth Seeking Alpha

   X     

1 week Vertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should Know Zacks

   X     

1 week Is Invesco Pharmaceuticals ETF (PJP) a Strong ETF Right Now? Zacks

   X     

1 week Vertex Pharmaceuticals (VRTX) Advances While Market Declines: Some Information for Investors Zacks

   X     

1 week 2025 drug price rise: Pharma companies plan to make more than 250 medicines more expensive Fast Company

   X     

1 week Sangamo Therapeutics’ stock falls the most in 16 years after Pfizer ends hemophilia pact MarketWatch

   X     

1 week Sangamo Therapeutics Stock Crashes as Pfizer Ends Hemophilia Drug Pact Yahoo Finance

   X     

1 week Sangamo Therapeutics Stock Plummets 56% After Pfizer Ends Hemophilia Treatment Partnership Yahoo Finance

   X     

1 week Sangamo Plunges After Pfizer Ends Pact for Hemophilia Drug Yahoo Finance

   X     

1 week Here’s Why Acadia Pharmaceuticals (ACAD) is a Strong Momentum Stock Zacks

   X     

1 week Sangamo Therapeutics Stock Plunges As Pfizer Terminates Hemophilia Gene Therapy Pact Yahoo Finance

   X     

1 week Vertex Pharmaceuticals: Jim Cramer Fires A Warning Shot But I Remain Invested Seeking Alpha

   X     

1 week Sangamo’s stock sinks 50% as Pfizer halts haemophilia A gene therapy partnership Yahoo Finance

   X     

1 week NIH settlement ‘manageable headwind’ for BioNTech, Pfizer, says Morgan Stanley Yahoo Finance

   X     

1 week Wedbush starts Rocket Pharmaceuticals with Outperform into ‘inflection year’ Yahoo Finance

   X     

1 week 3 Reasons to Buy Pfizer Stock Like There’s No Tomorrow Yahoo Finance

   X     

1 week Marinus Pharmaceuticals to be acquired by Immedica for 55c per share Yahoo Finance

   X     

1 week Citius Pharmaceuticals upgraded to Buy from Hold at D. Boral Capital Yahoo Finance

   X     

1 week Sangamo stock crashes 50% after Pfizer terminates HemoA gene therapy deal Investing.com

   X     

1 week SGMO Stock Crashes as Pfizer Ends Deal for Hemophilia Candidate Zacks

   X     

1 week Centessa Pharmaceuticals: Orexin Franchise Worth Monitoring Seeking Alpha

   X     

1 week Pfizer ends global collaboration with Sangamo, shares drop 27% Investing.com

   X     

1 week Pfizer: One Of The Next Big AI Winners Seeking Alpha

   X     
More news +
Home | Contact
  • X

© 2025 The Stock Market News